The U.S. Protein Supplements market size was valued at US$ 2,112.30 Million in 2021 and is expected to hit US$ 4,285.07 Million by 2030, growing at a compound annual growth rate (CAGR) of 9.7% from 2022 to 2030.
Growth Factors:
Over the past of couple of years, there has been a rise in number of health-conscious customers around the globe. They look out for ways in adopting a healthy and an active lifestyle, which has fueled the demand for health-oriented food products.
Thus, protein supplement endures the same kind of traction in North America, Europe as well as Asia-Pacific regions. Healthy lifestyle is becoming a normal way of life that majorly has concerns over obesity, food sensitivity, and people affected by diseases continue to rise.
Major factors that are driving the growth of U.S. protein supplement industry are Increase in awareness among people for health & fitness, alarming rise in obesity rates, increase in disposable income, and rise in demand for supplement from the millennial population. Obesity has been a major issue since many years and number of overweight and obese people is greater than number of underweight people owing to availability of junk food and beverages at cheaper rates. Obese people are mostly expected to have high cholesterol and high blood pressure due to which they are more inclined toward these proteins supplements. Moreover, presently, protein supplements are used on a large scale due to rise in healthcare awareness among people and increase in obesity concerns. Due to rising health care awareness, people are ultimately shifting toward healthy diets and increasing their protein intake to get extra nutrients found in these supplements thereby fueling the market growth for protein supplements.
The demand for protein supplements from the young population is increasing mainly in athletes as they provide various benefits such as lowering cholesterol, building of muscles, increasing strength, fighting cancer, improving immunity, and lowering blood pressure. Thus, the market provides a great opportunity for the manufacturers in the future.
The report segments the U.S. protein supplement market based on type, form, source, gender, age group, and distribution channel. By type, the market is divided into casein, whey protein, egg protein, soy protein, and others. The whey protein segment was the highest contributor to the U.S. protein supplement market in 2019 and is estimated to dominate the market in 2028 growing at a moderate CAGR from 2022 to 2030. The soy protein segment is estimated to grow with highest CAGR of in this segment. On the basis of form, it is classified into powder, RTD liquid, and protein bars. These are generally available as protein powders in the market while RTD protein shakes and protein bars are comparatively new. On account of source, the market is segmented into animal and plant sources. The consumption of plant-based protein products has been witnessing rapid growth, which is driven by various factors such as rise in number of vegan populations, rise in number of lactose intolerant population and consumers being skeptical over the safety of animal protein consumption.
Report Scope of the U.S. Protein Supplements Market
Report Coverage |
Details |
Market Size in 2021 |
USD 2,112.30 Million |
Revenue Projection By 2030 |
USD 4,285.07 Million |
Growth Rate |
CAGR of 9.7% from 2022 to 2030 |
Base Year |
2021 |
Historical data |
2017 - 2020 |
Forecast Period |
2022 to 2030 |
Segments Covered |
Type, Form, Source , Gender, Age Group |
Companies Mentioned |
Abbott Laboratories, ABH Pharma Inc., Amway Corporation, Glanbia Corp., GlazoSmithKline, GNC Holdings, Herbalife International of America Inc., Bob's Red Mill, Nutiva Inc., and MusclePharm Corporation. The major strategies adopted by key players to expand their business include expansion in untapped regions and new product launches. |
On the basis of gender, the market is bifurcated into male and female. Women seek various specific food and nutrition products to support their active and healthy lifestyle and they expect the products to be easily adaptable to their lifestyle. On the basis of age group, the market is classified into millennial, generation X, and baby boomer. Millennial are more concerned about brain health, heart health, weight loss, weight maintenance, fighting fatigue, and maintaining high energy levels. This concern drives the demand for health promoting products such as probiotics, multivitamins tablets, fish oils, as well as protein supplements. Based on distribution channel, it is categorized into supermarkets/hypermarkets, e-commerce, chemist/drugstore, nutrition store, health food store, specialist sports store, and others. E-commerce is increasingly becoming a popular platform, as it has enabled consumers to buy foreign-manufactured protein supplements. Consumers now rely on internet for gaining information and even consider online shopping as the most convenient factor.
U.S. protein supplement market: covid-19 Impact analysis
During the COVID-19 outbreak, consumers have become more concerned about their overall health and wellness as COVID-19 has impacted mental and physical well-being of almost everyone across the globe.
Moreover, consumers are now more conscious about their immunity and weight gain, which has become an issue during the pandemic as people have become extremely inactive. Such factors have led to various chronic diseases such as diabetes and obesity and people are looking for healthy alternatives to combat the same. The protein supplement industry is expected to benefit from consumers, who want to lead healthier lifestyles and improve their dietary habits during and after COVID-19.
Some of the prominent players in the U.S. Protein Supplements Market include:
Abbott Laboratories, ABH Pharma Inc., Amway Corporation, Glanbia Corp., GlazoSmithKline, GNC Holdings, Herbalife International of America Inc., Bob's Red Mill, Nutiva Inc., and MusclePharm Corporation. The major strategies adopted by key players to expand their business include expansion in untapped regions and new product launches.
Segments Covered in the Report
This research report offers market revenue, sales volume, production assessment and prognoses by classifying it on the basis of various aspects. Further, this research study investigates market size, production, consumption and its development trends at U.S. for the period of 2017 to 2030
By Type
By Form
By Source
By Gender
By Age Group
Key Points Covered in U.S. Protein Supplements Market Study:
CHAPTER 1:INTRODUCTION
1.1.Report description
1.2.Key benefits for stakeholders
1.3.Key market segment
1.4.Research methodology
1.4.1.Primary research
1.4.2.Secondary research
1.4.3.Analyst tools and models
CHAPTER 2:EXECUTIVE SUMMARY
2.1.Key findings of the study
2.2.CXO perspective
CHAPTER 3:MARKET OVERVIEW
3.1.Market definition and scope
3.2.Key findings
3.2.1.Top investment pockets
3.3.Porter's five forces analysis
3.4.Market dynamics
3.4.1.Drivers
3.4.1.1.Increase in awareness among people for health & fitness
3.4.1.2.Alarming rise in obesity rates
3.4.1.3.Increase in disposable income
3.4.1.4.Rise in demand for supplement from the millennial population
3.4.2.Restraints
3.4.2.1.Presence of cheaper substitutes
3.4.2.2.Side-effects and negative publicity & claims
3.4.3.Opportunity
3.4.3.1.Growth in demand from young population
3.5.US protein supplement market: covid-19 Impact analysis
CHAPTER 4:U.S. PROTEIN SUPPLEMENT MARKET, BY TYPE
4.1.Overview
4.1.1.Market size and forecast
4.2.Casein
4.2.1.Key market trends, growth factors and opportunities
4.2.2.Market size and forecast
4.3.Whey protein
4.3.1.Key market trends, growth factors and opportunities
4.3.2.Market size and forecast
4.4.Egg protein
4.4.1.Key market trends, growth factors and opportunities
4.4.2.Market size and forecast
4.5.Soy protein
4.5.1.Key market trends, growth factors and opportunities
4.5.2.Market size and forecast
4.6.Others
4.6.1.Key market trends, growth factors and opportunities
4.6.2.Market size and forecast
CHAPTER 5:U.S. PROTEIN SUPPLEMENT MARKET, BY FORM
5.1.Overview
5.1.1.Market size and forecast
5.2.Powder
5.2.1.Key market trends, growth factors and opportunities
5.2.2.Market size and forecast
5.3.RTD liquid
5.3.1.Key market trends, growth factors and opportunities
5.3.2.Market size and forecast
5.4.Protein bar
5.4.1.Key market trends, growth factors and opportunities
5.4.2.Market size and forecast
CHAPTER 6:U.S. PROTEIN SUPPLEMENT MARKET, BY SOURCE
6.1.Overview
6.1.1.Market size and forecast
6.2.Animal
6.2.1.Key market trends, growth factors and opportunities
6.2.2.Market size and forecast
6.3.Plant
6.3.1.Key market trends, growth factors and opportunities
6.3.2.Market size and forecast
CHAPTER 7:U.S. PROTEIN SUPPLEMENT MARKET, BY GENDER
7.1.Overview
7.1.1.Market size and forecast
7.2.Male
7.2.1.Key market trends, growth factors and opportunities
7.2.2.Market size and forecast
7.3.Female
7.3.1.Key market trends, growth factors and opportunities
7.3.2.Market size and forecast
CHAPTER 8:U.S. PROTEIN SUPPLEMENT MARKET, BY AGE GROUP
8.1.Overview
8.1.1.Market size and forecast
8.2.Millennial
8.2.1.Key market trends, growth factors and opportunities
8.2.2.Market size and forecast
8.3.Generation X
8.3.1.Key market trends, growth factors and opportunities
8.3.2.Market size and forecast
8.4.Baby boomer
8.4.1.Key market trends, growth factors and opportunities
8.4.2.Market size and forecast
CHAPTER 9:U.S. PROTEIN SUPPLEMENT MARKET, BY DISTRIBUTION CHANNEL
9.1.Overview
9.1.1.Market size and forecast
9.2.Hypermarkets/Supermarkets
9.2.1.Key market trends, growth factors and opportunities
9.2.2.Market size and forecast
9.3.E-Commerce
9.3.1.Key market trends, growth factors and opportunities
9.3.2.Market size and forecast
9.4.Chemist/Drugstore
9.4.1.Key market trends, growth factors and opportunities
9.4.2.Market size and forecast
9.5.Nutrition store
9.5.1.Key market trends, growth factors and opportunities
9.5.2.Market size and forecast
9.6.Health food store
9.6.1.Key market trends, growth factors and opportunities
9.6.2.Market size and forecast
9.7.Specialist sports store
9.7.1.Key market trends, growth factors and opportunities
9.7.2.Market size and forecast
9.8.Others
9.8.1.Key market trends, growth factors and opportunities
9.8.2.Market size and forecast
CHAPTER 10:COMPETITION LANDSCAPE
10.1.Top winning strategies
10.2.Product mapping
10.3.Competitive dashboard
10.4.Competitive heat map
10.5.Key developments
10.5.1.Acquisition
10.5.2.Product Launch
10.5.3.Partnership
10.5.4.Agreement
CHAPTER 11:COMPANY PROFILES
11.1.ABBOTT LABORATORIES (ABBOTT)
11.1.1.Company overview
11.1.2.Key Executives
11.1.3.Company snapshot
11.1.4.Operating business segments
11.1.5.Product portfolio
11.1.6.R&D Expenditure
11.1.7.Business performance
11.1.8.Key strategic moves and developments
11.2.ABH PHARMA INC
11.2.1.Company overview
11.2.2.Key Executives
11.2.3.Company snapshot
11.2.4.Product portfolio
11.3.AMWAY CORPORATION (AMWAY)
11.3.1.Company overview
11.3.2.Key Executives
11.3.3.Company snapshot
11.3.4.Product portfolio
11.4.BOB'S RED MILL
11.4.1.Company overview
11.4.2.Key Executives
11.4.3.Company snapshot
11.4.4.Product portfolio
11.4.5.Key strategic moves and developments
11.5.GENERAL NUTRITION CORPORATION (GNC HOLDINGS, INC.)
11.5.1.Company overview
11.5.2.Key Executives
11.5.3.Company snapshot
11.5.4.Operating business segments
11.5.5.Product portfolio
11.5.6.R&D Expenditure
11.5.7.Business performance
11.5.8.Key strategic moves and developments
11.6.GLANBIA PLC.
11.6.1.Company overview
11.6.2.Key Executives
11.6.3.Company snapshot
11.6.4.Operating business segments
11.6.5.Product portfolio
11.6.6.R&D Expenditure
11.6.7.Business performance
11.6.8.Key strategic moves and developments
11.7.GLAXOSMITHKLINE PLC. (GSK)
11.7.1.Company overview
11.7.2.Key Executives
11.7.3.Company snapshot
11.7.4.Operating business segments
11.7.5.Product portfolio
11.7.6.R&D Expenditure
11.7.7.Business performance
11.7.8.Key strategic moves and developments
11.8.HERBALIFE INTERNATIONAL OF AMERICA INC.
11.8.1.Company overview
11.8.2.Key Executives
11.8.3.Company snapshot
11.8.4.Operating business segments
11.8.5.Product portfolio
11.8.6.Business performance
11.9.MUSCLEPHARM CORPORATION
11.9.1.Company overview
11.9.2.Key Executives
11.9.3.Company snapshot
11.9.4.Operating business segments
11.9.5.Product portfolio
11.9.6.R&D Expenditure
11.9.7.Business performance
11.9.8.Key strategic moves and developments
11.10.NUTIVA INC.
11.10.1.Company overview
11.10.2.Key Executives
11.10.3.Company snapshot
11.10.4.Product portfolio
11.10.5.Key strategic moves and developments